APH

ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCQB:APCSF) - 

On May 30, 2011, the Canadian Medical Association published an article
indicating that two new "superbugs", Morganella morganii, and Providencia
rettgeri, have spontaneously emerged in patients in Ontario. Both bacteria were
found to contain the gene for New Delhi metallo-beta-lactamase-1 ("NDM-1"), a
recently identified enzyme that confers resistance to a wide variety of
antibiotics. The gene for NMD-1 appears able to readily transfer between
different species of bacteria. Such "gene swapping" is very common among
bacteria but the transfer of the gene for NMD-1 is of particular concern to
health authorities because of the unusually broad range of antibiotic resistance
it provides. The full article can be found at www.cmaj.ca.


At this time in Canada, the organisms pose little risk outside hospital settings
as they are not transmitted through the air but can be passed from patient to
patient through hospital workers who do not properly wash their hands.


To reduce the spread of these and other resistant bacteria, health authorities
continue to recommend proper hand hygiene and disinfection procedures, using
products such as T36(R) Antiseptic Hand Sanitizer and T36 Disinfex(TM). As
previously reported by the Company both T36(R) Antiseptic Hand Sanitizer and T36
Disinfex(TM) have been subjected to 15 second tests against various "superbugs".
Copies of these reports are available on request. Because T36(R) formulations
disrupt the physical structures of infectious organisms, rather then interfering
with their metabolic pathways, the antibiotic resistance of "superbugs" confers
no protection against the Company's products.


About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection-control therapeutics derived
from its patented T36(R) technology. The company trades on the TSX Venture
Exchange under the symbol APH and on the OTCQB under the symbol APCSF. The
Company was the Official Supplier to the Vancouver 2010 Olympic Winter Games and
the Vancouver 2010 Paralympic Winter Games and is the Official Supplier to the
Canadian Olympic Committee, the 2010 Canadian Olympic Team and the 2012 Canadian
Olympic Team for antiseptic hand sanitizer, disinfectant and disinfectant
cleaning products. The Company was also selected as one of the TSX Venture 50
companies in the Technology and Life Sciences sector for 2010.


Terrance G. Owen, Ph.D., MBAPresident & CEO

ALDA Pharmaceuticals Corp.

www.aldacorp.com

Cautionary Note Regarding Forward-looking Statements: Information in this press
release that involves ALDA's expectations, plans, intentions or strategies
regarding the future are forward-looking statements that are not facts and
involve a number of risks and uncertainties. ALDA generally uses words such as
"outlook", "will", "could", "would", "might", "remains", "to be", "plans",
"believes", "may", "expects", "intends", "anticipates", "estimate", "future",
"plan", "positioned", "potential", "project", "remain", "scheduled", "set to",
"subject to", "upcoming", and similar expressions to help identify
forward-looking statements. The forward-looking statements in this release are
based upon information available to ALDA as of the date of this release, and
ALDA assumes no obligation to update any such forward-looking statements.
Forward-looking statements believed to be true when made may ultimately prove to
be incorrect. These statements are not guarantees of the future performance of
ALDA and are subject to risks, uncertainties and other factors, some of which
are beyond its control and may cause actual results to differ materially from
current expectations.

Aphria Inc. (TSXV:APH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024

Aphria Inc. (TSXV:APH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024